文献速递胸部技术与安全CT

基于CT的影像组学预测非小细胞肺癌PD-L1表达:系统综述与Meta分析

CT-Based Radiomics for Predicting PD-L1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · Acad Radiol · 2025-05-29

该系统综述与Meta分析检索5个数据库至2025年2月14日,定性纳入22项研究,Meta分析纳入11项研究共997例受试者,评估基于CT的影像组学模型预测NSCLC PD-L1表达状态。TPS1模型的合并AUC、敏感度、特异度分别为0.85、0.76、0.79,TPS50模型分别为0.88、0.72、0.86。结论认为CT影像组学作为无创预测PD-L1表达的方法展现出较强潜力,但存在显著方法学缺陷,需解决以实现临床应用的泛化性和可靠性。

要点

  • TPS1模型合并AUC 0.85、敏感度0.76、特异度0.79;TPS50模型合并AUC 0.88、敏感度0.72、特异度0.86。
  • QUADAS-2评估显示流程与时机及指标试验领域存在偏倚风险。
  • METRICS评分平均58.1%、范围24%至83.4%,提示方法学存在局限。

核心结论

  • 基于CT的影像组学作为无创预测NSCLC PD-L1表达的方法展现出较强潜力,但存在显著方法学缺陷,需解决以实现临床应用所需的泛化性和可靠性。

研究设计与样本

  • 系统综述与Meta分析;定性合成纳入22项研究,Meta分析纳入11项研究共997例受试者;系统检索Scopus、PubMed、Web of Science、Embase和IEEE数据库至2025年2月14日;从按肿瘤比例评分(TPS)1%(TPS1)和50%(TPS50)分类患者的模型验证队列中分别提取数据并分析;使用METRICS和QUADAS-2工具进行质量评估;采用双变量随机效应方法进行诊断试验准确性Meta分析以合并性能指标。

诊断标准与关键数值

  • TPS1模型合并AUC 0.85,敏感度0.76,特异度0.79。
  • TPS50模型合并AUC 0.88,敏感度0.72,特异度0.86。

局限性

  • QUADAS-2工具在流程与时机及指标试验领域发现存在显著偏倚风险。
  • METRICS评分提示存在方法学局限,平均58.1%、范围24%至83.4%。
  • 原文结论指出存在显著方法学缺陷,需解决以实现临床应用所需的泛化性和可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The efficacy of immunotherapy in non-small cell lung cancer (NSCLC) is intricately associated with baseline PD-L1 expression rates. The standard method for measuring PD-L1 is immunohistochemistry, which is invasive and may not capture tumor heterogeneity. The primary aim of the current study is to assess whether CT-based radiomics models can accurately predict PD-L1 expression status in NSCLC and evaluate their quality and potential gaps in their design.

MATERIALS AND METHODS: Scopus, PubMed, Web of Science, Embase, and IEEE databases were systematically searched up until February 14, 2025, to retrieve relevant studies. Data from validation cohorts of models that classified patients by tumor proportion score (TPS) of 1% (TPS1) and 50% (TPS50) were extracted and analyzed separately. Quality assessment was performed through METRICS and QUADAS-2 tools. Diagnostic test accuracy meta-analysis was conducted using a bivariate random-effects approach to pool values of performance metrics.

RESULTS: The qualitative synthesis included twenty-two studies, and the meta-analysis analyzed 11 studies with 997 individual subjects. The pooled AUC, sensitivity, and specificity of TPS1 models were 0.85, 0.76, and 0.79, respectively. The pooled AUC, sensitivity, and specificity of TPS50 models were 0.88, 0.72, and 0.86, accordingly. The QUADAS-2 tool identified a substantial risk of bias regarding the flow and timing and index test domains. Certain methodological limitations were highlighted by the METRICS score, which averaged 58.1% and ranged from 24% to 83.4%.

CONCLUSION: CT-based radiomics demonstrates strong potential as a non-invasive method for predicting PD-L1 expression in NSCLC. While promising, significant methodological gaps must be addressed to achieve the generalizability and reliability required for clinical application.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Salimi M, Vadipour P, Khosravi A, et al. CT-Based Radiomics for Predicting PD-L1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. Acad Radiol. 2025. PMID: 40447508. doi:10.1016/j.acra.2025.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。